Literature DB >> 209768

Gel double immunodiffusion studies with sex human rhinoviruses.

C B Smith.   

Abstract

Rabbits were immunized on six occasions during a seven month period with fluorocarbon and sucrose denstiy gradient purified preparations of human rhinovirus types 1A,2,3,4,9, OR 14. Sera collected 1 week after the final immunization formed 1 or 2 preciptin lines when reacted by immunodiffusion against fluorocarbon purified preparations of each homologous immunizing virus. Heterologous preciptin cross reactions were detected between: RV1A antigen and rabbit sera to RV2, RV9 and RV14; RV2 antigen and sera to RV1A; RV14 antigen and sera to RV3. The heterologous "group" or C-antigenic nature of the cross reactions was suggested by the merging of heterologous preciptin lines formed against rabbit sera with "group" antibody preciptin lines formed against human sera and by the location of heterologous reaction close to the antigen well. In addition, the presence of C-antigenic particles in the fluorocarbon treated RV2 preparation was suggested by the demonstration that a subpopulation of viral particles migrated to a pH of 4.4 by isoelectric focusing.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209768     DOI: 10.1007/bf01315087

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  ANTIBODY RESPONSES OF RHESUS (MACACA MULATTA) MONKEYS EXPERIMENTALLY INFECTED WITH COXSACKIEVIRUSES OF GROUP B AND GROUP A, TYPE 9. I. ANTIBODY RESPONSES WITH THE COXSACKIEVIRUS GROUP.

Authors:  N J SCHMIDT; J DENNIS; E H LENNETTE; H H HO; T T SHINOMOTO
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

2.  Gel double diffusion studies with group B and group A, type 9 Coxsackie viruses. I. The technique and reactions obtained with hyperimmune animal sera and human sera.

Authors:  N J SCHMIDT; E H LENNETTE
Journal:  J Immunol       Date:  1962-07       Impact factor: 5.422

3.  Fractionation of biologically active and inactive populations of human rhinovirus type 2.

Authors:  B D Korant; K Lonberg-Holm; F H Yin; J Noble-Harvey
Journal:  Virology       Date:  1975-02       Impact factor: 3.616

4.  Acid lability of rhinoviruses: loss of C and D antigenicity after treatment at pH 3.0.

Authors:  J H Hughes; S Chema; N Lin; R M Conant; V V Hamparian
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

5.  A complement fixing antigen from an M rhinovirus (brief report).

Authors:  P J Chapple; B Head; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1967

6.  Density of infectious virus and complement-fixing antigens of two rhinovirus strains.

Authors:  P E Dans; B R Forsyth; R M Chanock
Journal:  J Bacteriol       Date:  1966-04       Impact factor: 3.490

7.  A method for producing specific antisera with small doses of immunogen.

Authors:  J Vaitukaitis; J B Robbins; E Nieschlag; G T Ross
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

8.  Picornaviruses: rapid differentiation and identification by immune electronmicroscopy and immunodiffusion.

Authors:  J H Hughes; J M Gnau; M D Hilty; S Chema; A C Ottolenghi; V V Hamparian
Journal:  J Med Microbiol       Date:  1977-05       Impact factor: 2.472

9.  Broad antigenic relationships among rhinovirus serotypes revealed by cross-immunization of rabbits with different serotypes.

Authors:  M K Cooney; J A Wise; G E Kenny; J P Fox
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

10.  Rhinoviruses.

Authors:  J M Gwaltney
Journal:  Yale J Biol Med       Date:  1975-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.